This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Translational Technologies, LLC. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: Christopher Mark Gleason: Innovator in Extracorporeal Shockwave Lithotripsy
Introduction
Christopher Mark Gleason is a notable inventor based in Tucson, AZ (US). He has made significant contributions to the field of medical technology, particularly in the area of extracorporeal shockwave lithotripsy (ESWL). His innovative approach aims to enhance therapeutic outcomes for patients undergoing this procedure.
Latest Patents
Gleason holds a patent for an "Extracorporeal shockwave lithotripsy (ESWL) system and method using in-situ sensing of system and device data and therapeutic/system/device level control." This invention provides enhanced ESWL efficacy for therapeutic and operational outcomes. The device behavior and performance data are measured in-situ and analyzed for both intra-procedure and inter-procedure breadth of regard. This allows for therapy optimization and maintenance optimization, providing an accurate and current assessment of the ESWL system and device state and performance. The feedback and control mechanisms enable real-time compensation for current patient therapy and offline adjustments for future patient therapy, ensuring continuous calibration of systems and devices for maximum ESWL patient efficacy.
Career Highlights
Gleason's career is marked by his dedication to advancing medical technology. His work has focused on improving patient outcomes through innovative device design and functionality. His patent reflects his commitment to enhancing the efficacy of medical treatments.
Collaborations
Gleason collaborates with Andrew James Griffis, contributing to the development and refinement of medical technologies. Their partnership emphasizes the importance of teamwork in driving innovation in the healthcare sector.
Conclusion
Christopher Mark Gleason is a pioneering inventor whose work in extracorporeal shockwave lithotripsy has the potential to significantly improve patient care. His innovative patent showcases his commitment to advancing medical technology and enhancing therapeutic outcomes.